Why the study?
Does primary PTCA reduce mortality, reinfarction, and stroke compared with thrombolytic therapy in patients with acute myocardial infarction?
Population
2606 patients with acute myocardial infarction (from 10 randomized trials)
Comparison
Primary percutaneous transluminal coronary… vs Thrombolytic therapy
Design
Editorial
Authors
Loading...
This editorial discusses a meta-analysis showing primary PTCA reduces mortality, reinfarction, and stroke compared to thrombolytic therapy in acute MI, while cautioning about potential biases.
Does primary PTCA reduce mortality, reinfarction, and stroke compared with thrombolytic therapy in patients with acute myocardial infarction?
Salim Yusuf (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: